Medifast, Inc. (NYSE: MED) reported Q2 EPS of $0.44, $0.05 better than the analyst estimate of $0.39. Revenue for the quarter came in at $80.9 million versus the consensus estimate of $87.3 million.

Medifast, Inc. sees Q3 2014 EPS of $0.35-$0.37, versus the consensus of $0.54. Medifast, Inc. sees Q3 2014 revenue of $75-78 million, versus the consensus of $91.1 million.

Medifast, Inc. sees FY2014 EPS of $1.80-$1.85, versus the consensus of $1.83. Medifast, Inc. sees FY2014 revenue of $320-330 million, versus the consensus of $344.55 million.

"We are pleased with our ability to deliver second quarter earnings results ahead of our guidance," said Michael C. MacDonald, Medifast's Chairman and Chief Executive Officer. "We continue to be diligent in managing our business in order to maximize our long-term profitability. Our team remains intently focused on executing our strategic objectives, including health coach expansion and product innovation, to enable us to achieve another successful year for Medifast."

For earnings history and earnings-related data on Medifast, Inc. (MED) click here.